New HESI Global research is helping advance in vitro methods for identifying seizure risk earlier and more reliably.
In an international, multi-laboratory study, researchers evaluated multielectrode array (MEA) technology using two neuronal cell models:
• Human induced pluripotent stem cell-derived neural co-cultures (with glutamatergic and GABAergic neurons and astrocytes)
• Primary rat cortical neurons
Both models detected seizure-related activity. However, the human-derived model produced more consistent results across laboratories.
These findings support the development of human-relevant approaches that could:
• Strengthen neurotoxicity testing
• Improve drug and chemical safety
• Reduce reliance on animal testing
This collaborative work reflects HESI’s mission to bring scientists together to develop innovative solutions for global health challenges.
Read the full publication: Roberts et al., 2026. Detection of seizurogenic compounds in human and rat neurons in vitro: A multi-laboratory, multi-model assessment. Neuro Toxicology. https://doi.org/10.1016/j.neuro.2026.103519
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-8403
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.